Rocket Lab logged higher-than-expected revenue in the third quarter, and its fourth-quarter outlook beat analyst expectations. The aerospace company said revenue surged 55% to $104.8 million, ahead of ...

Watertown, Mass., added millions of square feet of lab space in just a few years. Here's how it happened, and why the pace ...

This question, along with the knowledge that there wasn’t supplemental fertility insurance unless she worked at a large ...

“As the industry transitions from traditional drug discovery and life sciences R&D to faster-paced, complex modalities, ...

Advocates of making fertility treatments more affordable weigh in on President-elect Donald Trump’s campaign promise that the government would cover IVF treatment or mandate that insurers ...

Ambry’s “secret sauce” is its interpretation of the results, finding abnormalities that no other lab can find. The company ...

In a report released on November 7, Patrick B Donnelly from Citi maintained a Sell rating on Charles River Labs (CRL – Research Report).

Mizuho Securities analyst Ann Hynes has maintained their neutral stance on CRL stock, giving a Hold rating yesterday. Ann Hynes’s rating ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

A protocol for differentiating visceral sensory ganglion organoids from induced pluripotent stem cells allows the establishment of an in vitro model for the gut–visceral nerve–brain axis and ...

In Georgia, House Speaker John Burns has a resolution to protect IVF that hasn’t been voted on. But Baston is worried. She got pregnant with twins through IVF after her egg split. But her joy was ...

Yourgene Health (part of the Novacyt group of companies ... a Class C in vitro medical device under IVDR and is intended for use by healthcare professionals within a molecular laboratory environment.